Contributor:
Vondran, Maximilian;
Abt, Bernd;
Nef, Holger;
Rastan, Ardawan J.
imprint:
Georg Thieme Verlag KG, 2021
Published in:The Thoracic and Cardiovascular Surgeon Reports
Language:
English
DOI:
10.1055/s-0040-1721483
ISSN:
2194-7643;
2194-7635
Origination:
Footnote:
Description:
<jats:title>Abstract</jats:title><jats:p>Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs). The new self-expanding transcatheter heart valve Allegra, from New Valve Technology with its special implantation mechanism, has proven its safety and feasibility for patients with degenerated SAVs, but it has never been used in the latest-generation sutureless SAV. To the best of our knowledge, this is the first description of the successful VIV of the Allegra prosthesis into a degenerated sutureless SAV, and the procedure yielded an excellent postinterventional hemodynamic results.</jats:p>